for Neurodegenerative Diseases Caused by Protein Misfolding.
Führungspositionen
Name & Titel
Biographie
Tony Coles
CEO / President
Tony Coles serves as the CEO / President of Yumanity Therapeutics.
Marie Epstein
Vice President Finance
Marie Epstein serves as the Vice President Finance of Yumanity Therapeutics.
Ken Rhodes
Chief Scientific Officer
Ken Rhodes serves as the Chief Scientific Officer of Yumanity Therapeutics. Ken started at Yumanity Therapeutics in October of 2014. Ken currently resides in Greater Boston Area.
Paulash Mohsen
Chief Business Officer
Paulash Mohsen serves as the Chief Business Officer of Yumanity Therapeutics.
Robert Scannevin
Vice President, Discovery Biology
Robert Scannevin serves as the Vice President, Discovery Biology of Yumanity Therapeutics. Robert currently resides in the Greater Boston Area.
Bertrand Bourdonnec
Vice President, Medicinal Chemistry & Program Management
Bertrand Bourdonnec serves as the Vice President, Medicinal Chemistry & Program Management of Yumanity Therapeutics. Bertrand currently resides in the Greater Boston Area.
Matt Lucas
Senior Director Of Chemistry
Matt Lucas serves as the Senior Director Of Chemistry of Yumanity Therapeutics.
Lassen Sie Yumanity Therapeutics wissen, dass Sie dort arbeiten möchten
Sagen Sie Yumanity Therapeutics, dass Sie interessiert sind dort zu arbeiten, ihre persönlichen Informationen bleiben dabei anonym. Comparably gibt Yumanity Therapeutics die Gelegenheit, Sie anzustellen. Wenn es eine passende Stelle gibt, matchen wir diese.
Gleichberechtigungs BewertungWie positiv bewerten Frauen ihre Gesamterfahrung mit Yumanity Therapeutics
N/A
Herkunftsvielfalts BewertungWie positiv bewerten Minderheiten ihre Gesamterfahrung mit Yumanity Therapeutics